FDA Announces Change in Status of 12 Peptides SSRP Institute Big news for peptides! In July, the FDA will meet to evaluate the most commonly used peptides for FDA authorized compounding. The Peptide Landscape Is Shifting: What Secretary Kennedy's Joe Rogan Interview Could Mean for the Compounding Industry Frier Levitt FDA Peptide Regulation May Shift: What RFK Jr.'s Announcement Means for Compounding FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of